The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression-Reference-Cited by-同舟云学术

The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression

Published:2018-05 Issue:5 Volume:23 Page:1476-1490
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Goyette Marie-Anne,Duhamel Stéphanie,Aubert Léo,Pelletier Ariane,Savage Paul,Thibault Marie-Pier,Johnson Radia Marie,Carmeliet Peter,Basik Mark,Gaboury Louis,Muller William J.,Park Morag,Roux Philippe P.,Gratton Jean-Philippe,Côté Jean-François

Funder

Canadian Institute of Health Research

Réseau de Recherche en Cancer of the FRQS

Quebec Breast Cancer Foundation

CIHR

Cole Foundation

FRQS

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference51 articles.

1. The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancer;Antony;Sci. Signal.,2016

2. AXL induces epithelial-to-mesenchymal transition and regulates the function of breast cancer stem cells;Asiedu;Oncogene,2014

3. Phosphoproteomic analysis of Her2/neu signaling and inhibition;Bose;Proc. Natl. Acad. Sci. USA,2006

4. Molecular classification and molecular forecasting of breast cancer: ready for clinical application?;Brenton;J. Clin. Oncol.,2005

5. Axl receptor tyrosine kinase expression in breast cancer;D’Alfonso;J. Clin. Pathol.,2014

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinct tumor architectures and microenvironments for the initiation of breast cancer metastasis in the brain;Cancer Cell;2024-09

2. Ferroptosis – a potential feature underlying neratinib-induced colonic epithelial injury;Cancer Chemotherapy and Pharmacology;2024-07-13

3. VGLL1 stabilization of cytoplasmic TAZ promotes EGFR expression and maintains tumor initiating cells in breast cancer independent of TEAD;Cellular Signalling;2024-06

4. Disrupting EGFR–HER2 Transactivation by Pertuzumab in HER2-Positive Cancer: Quantitative Analysis Reveals EGFR Signal Input as Potential Predictor of Therapeutic Outcome;International Journal of Molecular Sciences;2024-05-29

5. Hippo and PI5P4K signaling intersect to control the transcriptional activation of YAP;Science Signaling;2024-05-28